Close
  Indian J Med Microbiol
 

Figure 1: Wound dehiscence and scleral exposure in the first patient, 10 days after Ahmed Glaucoma Valve implantation with adjunctive subconjunctival bevacizumab.

Figure 1: Wound dehiscence and scleral exposure in the first patient, 10 days after Ahmed Glaucoma Valve implantation with adjunctive subconjunctival bevacizumab.